BCP-ALL cells can be distinguished from normal B-cells by abnormal expression of known maturation makers (e.g., CD10, CD20, CD34, and CD45) combined with aberrant expression of other markers (e.g., CD58, CD81, CD304, CD73, CD66c, and CD123). This evidence concerns the gene MME and acute lymphoblastic leukemia.